Sort
78,016 grants matching “breast cancer”
A Prospective, Randomized Study to Compare Effects of Ulipristal Acetate with a Combined Oral Contraceptive on Breast Epithelial Cell Proliferation.
$439,302Carolyn L Westhoff · Columbia University Health Sciences · R01 · FY2016 · CA
Chemical Probes for Metabolic Pathway Discovery in Human Disease
$439,287Benjamin F Cravatt · Scripps Research Institute, The · R01 · FY2010 · CA
Humanized mouse models to dissect in vivo the interplay between melanoma and the immune system
$439,280Anna Karolina Palucka · Jackson Laboratory · R01 · FY2017 · CA
TARGETING HUMAN RHOMBOID FAMILY-1 GENE RHBDF 1 IN BREAST CANCER
$439,236University Of Pittsburgh - Of The Commonwealth System Of Higher Education · · FY2008 · Department of the Army
TGF-beta Suppression and Promotion of Mammary Carcinomas
$439,217Harold L Moses · Vanderbilt University · R01 · FY2014 · CA
Multiplexed functional analysis of BRCA1and BARD1 missense variants in DNA repair
$439,207Jeffrey D Parvin · Ohio State University · R01 · FY2023 · CA
Multiplexed functional analysis of BRCA1and BARD1 missense variants in DNA repair
$439,207Jeffrey D Parvin · Ohio State University · R01 · FY2022 · CA
Probing the role of epigenomics in Brca1-deficient mammary tumors.
$439,200Camila Dos Santos · Cold Spring Harbor Laboratory · R01 · FY2021 · CA
Identification and development of inhibitors of the Hippo-Yap pathway
$439,200Joseph Kissil · Scripps Florida · R01 · FY2016 · CA
Identification and development of inhibitors of the Hippo-Yap pathway
$439,200Joseph Kissil · Scripps Florida · R01 · FY2015 · CA
Probing the role of epigenomics in Brca1-deficient mammary tumors.
$439,200Camila Dos Santos · Cold Spring Harbor Laboratory · R01 · FY2020 · CA
Bi-directional interactions with tumor microenvironment enhance BRCA1-IRIS overexpressing TNBC tumor cells aggressiveness
$439,200Wael M. Elshamy · San Diego Biomedical Research Institute · R01 · FY2018 · CA
Leadership, Administration and Statisitical Analysis
$439,191Susan E. Hankinson · Brigham And Women'S Hospital · P01 · FY2012 · CA
Homologous Recombination and Crosslink Repair
$439,177Patrick Sung · University Of Calif-Lawrenc Berkeley Lab · P01 · FY2007 · CA
DEVELOPMENT OF GOGGLE SYSTEM FOR FLUORESCENCE IMAGE-GUIDED SURGERY
$439,171Samuel Achilefu · Washington University · R01 · FY2017 · CA
The Allee Effect in Tumor Initiation
$439,171Amy Brock · University Of Texas At Austin · R01 · FY2022 · CA
TSPO Ligands for Cancer Imaging
$439,157Henry Charles Manning · Vanderbilt University · R01 · FY2014 · CA
Structure meets function for OATP1B1, a transporter involved in the uptake of endogenous and xenobiotic materials and drugs
$439,154Aviv Paz · Hauptman-Woodward Medical Research Inst · R01 · FY2024 · GM
Blocking cardiac toxicity of anticancer drugs
$439,139Mahesh P Gupta · University Of Chicago · R01 · FY2014 · HL
Glycomics Laboratory for the Early Detection of Epithelial Ovarian Cancer
$439,135Karen L. Abbott · Univ Of Arkansas For Med Scis · U01 · FY2014 · CA
Novel Targeted Anticancer Agents from Marine Cyanobacteria
$439,130Hendrik Luesch · University Of Florida · R01 · FY2021 · CA
Novel Targeted Anticancer Agents from Marine Cyanobacteria
$439,130Hendrik Luesch · University Of Florida · R01 · FY2020 · CA
Etiologic Studies of Prostate Cancer
$439,110Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA
Boosting Antitumor Immunity by Blocking Both Tumor and Adipose DDR1
$439,100Rong Li · George Washington University · R01 · FY2024 · CA
RHO GTPASES AND BREAST CANCER CELL DORMANCY
$439,086University Of Delaware · · FY2008 · Department of Defense